MX2016005576A - Composicion herbaria, procedimiento para su preparacion y uso de la misma. - Google Patents

Composicion herbaria, procedimiento para su preparacion y uso de la misma.

Info

Publication number
MX2016005576A
MX2016005576A MX2016005576A MX2016005576A MX2016005576A MX 2016005576 A MX2016005576 A MX 2016005576A MX 2016005576 A MX2016005576 A MX 2016005576A MX 2016005576 A MX2016005576 A MX 2016005576A MX 2016005576 A MX2016005576 A MX 2016005576A
Authority
MX
Mexico
Prior art keywords
preparation
relates
present
herbal composition
momordica charantia
Prior art date
Application number
MX2016005576A
Other languages
English (en)
Inventor
Ajay Piramal Swati
Chandrakant Suthar Ashish
Ramesh SHELAR Rahul
Original Assignee
Piramal Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Entpr Ltd filed Critical Piramal Entpr Ltd
Publication of MX2016005576A publication Critical patent/MX2016005576A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/13—Preparation or pretreatment of starting material involving cleaning, e.g. washing or peeling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/31—Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención se refiere a un extracto estandarizado de Momordica charantia que contiene uno o más compuestos heterocíclicos que contienen nitrógeno en calidad de marcadores bioactivos y a un procedimiento para la preparación del mismo. La presente invención se refiere también a una composición que contiene el extracto estandarizado de Momordica charantia que contiene uno o más compuestos heterocíclicos que contienen nitrógeno en calidad de los marcadores bioactivos. La presente invención se refiere también al uso del extracto estandarizado de Momordica charantia o a la composición que contiene dicho extracto estandarizado para el tratamiento de trastornos metabólicos tales como diabetes.
MX2016005576A 2013-10-28 2014-10-28 Composicion herbaria, procedimiento para su preparacion y uso de la misma. MX2016005576A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361896321P 2013-10-28 2013-10-28
PCT/IB2014/065649 WO2015063674A1 (en) 2013-10-28 2014-10-28 Herbal composition, process for its preparation and use thereof

Publications (1)

Publication Number Publication Date
MX2016005576A true MX2016005576A (es) 2016-12-09

Family

ID=53003431

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016005576A MX2016005576A (es) 2013-10-28 2014-10-28 Composicion herbaria, procedimiento para su preparacion y uso de la misma.

Country Status (13)

Country Link
US (1) US20160296577A1 (es)
EP (1) EP3062803A4 (es)
JP (1) JP2016535746A (es)
KR (1) KR20160066558A (es)
CN (1) CN105682670A (es)
AU (1) AU2014343262A1 (es)
CA (1) CA2928542A1 (es)
CL (1) CL2016000998A1 (es)
IL (1) IL245296A0 (es)
MX (1) MX2016005576A (es)
PH (1) PH12016500775A1 (es)
RU (1) RU2016120665A (es)
WO (1) WO2015063674A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105054253A (zh) * 2015-07-27 2015-11-18 广西鹿寨方田贸易有限公司 罗汉果烘干方法
US10675319B2 (en) 2016-06-21 2020-06-09 Tci Co., Ltd. Method for regulating circadian clock, regulating diurnal preference, adjusting a biological clock, improving sleep quality and/or facilitating sleep by using momordica charantia extract
IT201700002235A1 (it) * 2017-06-07 2018-12-07 Arche Frama Srls Composizione per somministrazione orale utile nel trattamento del diabete e delle sindrome metaboliche in genere
PE20200613A1 (es) 2017-07-11 2020-03-11 Pfizer Composiciones inmunogenicas
CN110376294B (zh) * 2019-05-28 2021-07-23 神威药业集团有限公司 一种瓜蒌配方颗粒指纹图谱的构建方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6183747B1 (en) * 1999-07-14 2001-02-06 Kaijun Ren Use of plant Momordica charactia extracts for treatment of acne acid
KR20140038372A (ko) * 2011-01-28 2014-03-28 피라말 엔터프라이지즈 리미티드 약초 추출물의 제조방법
CN103284083B (zh) * 2012-02-24 2016-06-08 中科云健康科技(天津)有限公司 高维生素c含量的苦瓜干品及其制备方法

Also Published As

Publication number Publication date
KR20160066558A (ko) 2016-06-10
PH12016500775A1 (en) 2016-05-30
IL245296A0 (en) 2016-06-30
US20160296577A1 (en) 2016-10-13
CL2016000998A1 (es) 2017-01-20
EP3062803A1 (en) 2016-09-07
JP2016535746A (ja) 2016-11-17
RU2016120665A3 (es) 2018-06-09
AU2014343262A1 (en) 2016-06-02
CA2928542A1 (en) 2015-05-07
CN105682670A (zh) 2016-06-15
RU2016120665A (ru) 2017-12-01
WO2015063674A1 (en) 2015-05-07
EP3062803A4 (en) 2017-05-03

Similar Documents

Publication Publication Date Title
MX2021001091A (es) Compuestos para usarse en el tratamiento o mejoramiento de la enfermedad de huntington.
HK1213264A1 (zh) 经取代的苯化合物
MX2015008628A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
HK1204928A1 (en) Inhibitors of the notch signalling pathway and secretion for use in medicine
PH12016500775A1 (en) Herbal composition, process for its preparation and use thereof
MX2016004741A (es) Composicion farmaceutica que comprende un antagonista de trpa1 y un agente analgesico.
WO2015059463A3 (en) Treatment of beta-catenin related diseases8
PH12016502050A1 (en) Homovanillinic acid ester, in particular, for creating a hot and/or pungent taste sensation
SG11201709800RA (en) Composition for inhibiting and preventing myopathy, containing bean leaf extract as active ingredient
PH12017500348A1 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors
MY189930A (en) Glyt1 inhibitors for use in the treatment of hematological disorders
EP3006434A4 (en) Novel compound derived from plant of genus quamoclit and composition containing same as active ingredient for preventing or treating diabetes
EA201590564A1 (ru) Стабильные составы
IN2014DN09584A (es)
EP3144005A4 (en) Composition for preventing and treating male infertility, containing mixed herbal extract as active ingredient and use thereof
MX2016002930A (es) Moduladores del receptor x hepatico (lxr).
MX2016007955A (es) Pirrol carboxamidas iii fluorometil-sustituidas.
MX2016004094A (es) Composicion farmaceutica que comprende capecitabina y ciclofosfamida.
PL3019182T3 (pl) Kompozycja zawierająca oczyszczony wyciąg wyodrębniony z pseudolysimachion rotundum var. subintegrum zawierający dużą ilość składnika czynnego lub związki z niego wyodrębnione jako składnik czynny do zapobiegania lub leczenia przewlekłej obturacyjnej choroby płuc oraz jej zastosowania
PH12017500323A1 (en) P38 map kinase inhibiting indanyl urea compounds
MX2016007956A (es) Pirrol carboxamidas fluorometil-sustituidas como bloqueadores del canal de calcio de cav2.2.
PL3415142T3 (pl) Kompozycja do leczenia zapalenia brzegów powiek zawierająca terpinen-4-ol